Oxford BioTherapeutics to Announce New Fully Integrated ADC Engine at World ADC Conference 2023
March 09, 2023 04:00 ET
|
Oxford BioTherapeutics
Engine will combine OBT’s internationally recognised target discovery and ADC development capabilitiesOBT will also present a case study and two abstracts focussing on its recent novel target...
Oxford BioTherapeutics wins Tech Company of the Year and Special Recognition Award at Thames Valley SME Growth 100 Awards
March 07, 2023 04:00 ET
|
Oxford BioTherapeutics
Oxford BioTherapeutics wins Tech Company of the Year and Special Recognition Award at Thames Valley SME Growth 100 Awards Oxford, UK and San Jose, Calif., 7 March 2023- Oxford BioTherapeutics...